GRAND JURY TARGET

GRAND JURY TARGET

Tracking Key Issues in White Collar Prosecutions

Menu Skip to content
  • Home
  • About Sara and Andrea
  • Disclaimers
  • Contact

Tag: Pharmaceutical industry

June 12, 2014June 17, 2020 Kropf Moseley

Is This Trade Secrets Prosecution Crumbling? An Update on the Eli Lilly Case

May 15, 2014June 17, 2020 Kropf Moseley

The Secret Life of the Director of Financial Reporting: Guilty Plea by Celgene Corp. Executive for Insider Trading Scheme

October 29, 2013June 17, 2020 Kropf Moseley

Protecting Trade Secrets—Even for Eli Lilly—Is No Easy Matter: Two Scientists Indicted for Sharing Research with Chinese Competitor

Published By:

Contact Us

1100 H Street, NW
Suite 1220
Washington, DC 20005
202-627-6900
www.kmlawfirm.com
sara@kmlawfirm.com
andrea@kmlawfirm.com

Get Social

  • LinkedIn
  • Twitter

Follow via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 212 other subscribers

Categories

Appeal Attorney client privilege Bribery civil case Conspiracy Conviction After Jury Trial Criminal Forfeiture Criminal Investigation Discovery/Brady Dismissal of charges in indictment DOJ policy and practice DOJ Statements False statements Government contracting fraud Health care fraud Indictment Insider Trading Mail Fraud Misc Money Laundering Obstruction OIG investigations Plea Agreement Public Corruption Search warrant SEC Investigation SEC policy and practice Securities fraud Sentencing Wire Fraud

© Kropf Moseley and Grand Jury Target Blog, 2013.

Powered by WordPress.com.
Newsletter Signup

Subscribe to our monthly newsletter and never miss a post.

Name
Email

Thanks, I’m not interested

 

Loading Comments...